168 related articles for article (PubMed ID: 19826450)
1. Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.
Plaitakis A; Latsoudis H; Kanavouras K; Ritz B; Bronstein JM; Skoula I; Mastorodemos V; Papapetropoulos S; Borompokas N; Zaganas I; Xiromerisiou G; Hadjigeorgiou GM; Spanaki C
Eur J Hum Genet; 2010 Mar; 18(3):336-41. PubMed ID: 19826450
[TBL] [Abstract][Full Text] [Related]
2. The human GLUD2 glutamate dehydrogenase and its regulation in health and disease.
Plaitakis A; Latsoudis H; Spanaki C
Neurochem Int; 2011 Sep; 59(4):495-509. PubMed ID: 21420458
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of glutamate dehydrogenase in human neurologic disorders.
Plaitakis A; Zaganas I; Spanaki C
J Neurosci Res; 2013 Aug; 91(8):1007-17. PubMed ID: 23463419
[TBL] [Abstract][Full Text] [Related]
4. Functional validation of a human GLUD2 variant in a murine model of Parkinson's disease.
Zhang W; Gong J; Ding L; Zhang Z; Pan X; Chen X; Guo W; Zhang X; Yang X; Peng G; Lin Y; Gao F; Li Y; Zhu X; Xuan A; Wang S; Sun X; Zhang Y; Xu P
Cell Death Dis; 2020 Oct; 11(10):897. PubMed ID: 33093440
[TBL] [Abstract][Full Text] [Related]
5. The human GLUD2 glutamate dehydrogenase: localization and functional aspects.
Zaganas I; Kanavouras K; Mastorodemos V; Latsoudis H; Spanaki C; Plaitakis A
Neurochem Int; 2009; 55(1-3):52-63. PubMed ID: 19428807
[TBL] [Abstract][Full Text] [Related]
6. Mutations in human GLUD2 glutamate dehydrogenase affecting basal activity and regulation.
Kanavouras K; Borompokas N; Latsoudis H; Stagourakis A; Zaganas I; Plaitakis A
J Neurochem; 2009 May; 109 Suppl 1():167-73. PubMed ID: 19393024
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.
Mastorodemos V; Zaganas I; Spanaki C; Bessa M; Plaitakis A
J Neurosci Res; 2005 Jan 1-15; 79(1-2):65-73. PubMed ID: 15578726
[TBL] [Abstract][Full Text] [Related]
8. Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.
Plaitakis A; Metaxari M; Shashidharan P
J Neurochem; 2000 Nov; 75(5):1862-9. PubMed ID: 11032875
[TBL] [Abstract][Full Text] [Related]
9. Substitution of Ser for Arg-443 in the regulatory domain of human housekeeping (GLUD1) glutamate dehydrogenase virtually abolishes basal activity and markedly alters the activation of the enzyme by ADP and L-leucine.
Zaganas I; Spanaki C; Karpusas M; Plaitakis A
J Biol Chem; 2002 Nov; 277(48):46552-8. PubMed ID: 12324473
[TBL] [Abstract][Full Text] [Related]
10. Expression of human GLUD2 glutamate dehydrogenase in human tissues: functional implications.
Zaganas I; Spanaki C; Plaitakis A
Neurochem Int; 2012 Sep; 61(4):455-62. PubMed ID: 22709674
[TBL] [Abstract][Full Text] [Related]
11. The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.
Spanaki C; Zaganas I; Kounoupa Z; Plaitakis A
Neurochem Int; 2012 Sep; 61(4):470-81. PubMed ID: 22658952
[TBL] [Abstract][Full Text] [Related]
12. The discovery of human of GLUD2 glutamate dehydrogenase and its implications for cell function in health and disease.
Shashidharan P; Plaitakis A
Neurochem Res; 2014; 39(3):460-70. PubMed ID: 24352816
[TBL] [Abstract][Full Text] [Related]
13. Human GLUD2 glutamate dehydrogenase is expressed in neural and testicular supporting cells.
Spanaki C; Zaganas I; Kleopa KA; Plaitakis A
J Biol Chem; 2010 May; 285(22):16748-56. PubMed ID: 20194501
[TBL] [Abstract][Full Text] [Related]
14. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
[TBL] [Abstract][Full Text] [Related]
15. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
[TBL] [Abstract][Full Text] [Related]
16. The odyssey of a young gene: structure-function studies in human glutamate dehydrogenases reveal evolutionary-acquired complex allosteric regulation mechanisms.
Zaganas IV; Kanavouras K; Borompokas N; Arianoglou G; Dimovasili C; Latsoudis H; Vlassi M; Mastorodemos V
Neurochem Res; 2014; 39(3):471-86. PubMed ID: 24515454
[TBL] [Abstract][Full Text] [Related]
17. Estrogen modification of human glutamate dehydrogenases is linked to enzyme activation state.
Borompokas N; Papachatzaki MM; Kanavouras K; Mastorodemos V; Zaganas I; Spanaki C; Plaitakis A
J Biol Chem; 2010 Oct; 285(41):31380-7. PubMed ID: 20628048
[TBL] [Abstract][Full Text] [Related]
18. Properties and molecular evolution of human GLUD2 (neural and testicular tissue-specific) glutamate dehydrogenase.
Kanavouras K; Mastorodemos V; Borompokas N; Spanaki C; Plaitakis A
J Neurosci Res; 2007 Apr; 85(5):1101-9. PubMed ID: 17253646
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of the positive selected human GLUD2 gene improves in vivo glucose homeostasis by regulating basic insulin secretion.
Petraki Z; Droubogiannis S; Mylonaki K; Chlouverakis G; Plaitakis A; Spanaki C
Metabolism; 2019 Nov; 100():153958. PubMed ID: 31400387
[TBL] [Abstract][Full Text] [Related]
20. Transgenic Mice Carrying GLUD2 as a Tool for Studying the Expressional and the Functional Adaptation of this Positive Selected Gene in Human Brain Evolution.
Plaitakis A; Kotzamani D; Petraki Z; Delidaki M; Rinotas V; Zaganas I; Douni E; Sidiropoulou K; Spanaki C
Neurochem Res; 2019 Jan; 44(1):154-169. PubMed ID: 29777493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
